PR Newswire
01 Sep 2022, 15:30 GMT+10
EAST RUTHERFORD, NJ, Sept. 1, 2022 /PRNewswire/ -- Cambrex today announced the completion of the first phase of its $30 million investment in its small molecule active pharmaceutical ingredient (API) manufacturing facility in High Point, North Carolina. The newly constructed space adds analytical and chemical development laboratories totaling 30,000 square feet and provides future workspace for 85 analytical and chemical development scientists. These laboratories will support the development of APIs to be manufactured in the facility's current clinical manufacturing area, as well as the future expanded clinical manufacturing and commercial manufacturing suites.
"With the growing number of therapies in clinical development and trend toward more targeted therapeutics, including orphan drugs, this expansion is preparing Cambrex to support the growing demand for small-scale API manufacturing," said Tom Loewald, CEO, Cambrex. "Our expansion goes beyond providing capacity - it provides state-of-the-art technology and laboratory equipment, an energy efficient infrastructure, and an ideal space for our scientific experts to work side-by-side with our clients."
Phase 2 of the project is ongoing and will approximately double the facility's manufacturing capacity with the addition of clinical and commercial manufacturing suites with reactors up to 2,000 liters. The new commercial area will provide an ideal scale for the manufacturing of orphan drugs and niche therapies, while larger volume products developed at the facility can be manufactured commercially at one of Cambrex's larger scale facilities in Iowa and Sweden. This expansion follows Cambrex's 2021 investment in the Cambrex High Point continuous flow R&D center of excellence, including expanded capabilities for continuous flow process development, manufacturing, and scale up.
Cambrex continues to expand its capabilities and capacity across its North American and European network to meet the growing demand for outsourced product development and manufacturing services.
About Cambrex
Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance, drug product, and analytical services across the entire drug lifecycle. With over 40 years of experience and a growing team of over 2,300 experts servicing global clients from North America and Europe, Cambrex is a trusted partner in branded and generic markets for API and finished dosage form development and manufacturing.
Cambrex offers a range of specialized drug substance technologies and capabilities, including biocatalysis, continuous flow, controlled substances, solid-state science, material characterization, stability storage, and highly potent APIs. In addition, Cambrex can support conventional dosage forms, including oral solids, semi-solids, and liquids, and has the expertise to manufacture specialty dosage forms such as modified-release, fixed-dose combination, pediatric, bi-layer tablets, stick packs, topicals, controlled substances, sterile, and non-sterile ointments.
Contact:
Jennifer Therrien
[email protected]
SOURCE Cambrex
Get a daily dose of Singapore Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Singapore Star.
More InformationSYDNEY, Australia: Australia's ruling Labor Party says it will raise the fee for international student visas to A$2,000 (US$1,279)...
WASHINGTON, D.C.: U.S. President Donald Trump said over the weekend that American military and business ships should be able to travel...
SINGAPORE: Singapore has ordered Facebook's parent company, Meta, to block Singaporeans from seeing posts made by three foreigners...
DES MOINES, Iowa: Iowa's governor has launched a lawsuit against the Des Moines Register, seeking to block the newspaper from obtaining...
DETROIT, Michigan: A former top official at a major Detroit nonprofit was sentenced this week to 19 years in prison for stealing over...
ALBUQUERQUE, New Mexico: Thousands of people are gathering in New Mexico for a big event that celebrates Native American and Indigenous...
BEIJING, China: China's Huawei Technologies is stepping up efforts to challenge U.S. dominance in artificial intelligence hardware,...
NEW YORK, New York - U.S. stocks forged higher and the U.S. dollar regained ground Thursday as investors shrugged off concerns about...
NEW YORK CITY, New York: Colgate-Palmolive posted stronger-than-expected quarterly results and raised its annual sales outlook last...
WASHINGTON, D.C.: President Donald Trump's administration warned over the weekend that it might limit livestock imports from Mexico...
SHANGHAI, China: Carmakers are stepping up their efforts to meet booming demand for long-range hybrids in China, the world's largest...
NEW YORK, New York - U.S. stocks closed mixed Wednesday after it was revealed the economy contracted in the first quarter, while import...